Revenue Breakdown
Composition ()
No data
Revenue Streams
Profitability & Margins
Evaluating the bottom line, Treace Medical Concepts Inc maintains a gross margin of 80.79%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 2.61%, while the net margin is 173.72%. These profitability ratios, combined with a Return on Equity (ROE) of 58.94%, provide a clear picture of how effectively TMCI converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, TMCI competes directly with industry leaders such as KEQU and BDMD. With a market capitalization of $120.14M, it holds a leading position in the sector. When comparing efficiency, TMCI's gross margin of 80.79% stands against KEQU's 28.13% and BDMD's 82.11%. Such benchmarking helps identify whether Treace Medical Concepts Inc is trading at a premium or discount relative to its financial performance.
